MeVis Medical Solutions AG

DB:M3V Stock Report

Market Cap: €47.3m

MeVis Medical Solutions Past Earnings Performance

Past criteria checks 2/6

MeVis Medical Solutions's earnings have been declining at an average annual rate of -8%, while the Healthcare Services industry saw earnings growing at 6.7% annually. Revenues have been declining at an average rate of 0% per year. MeVis Medical Solutions's return on equity is 27.6%, and it has net margins of 28.4%.

Key information

-8.0%

Earnings growth rate

-8.0%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate-0.0009%
Return on equity27.6%
Net Margin28.4%
Next Earnings Update27 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How MeVis Medical Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:M3V Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2317510
30 Jun 2318610
31 Mar 2319610
31 Dec 2219710
30 Sep 2219810
30 Jun 2218700
31 Mar 2217600
31 Dec 2116500
30 Sep 2116500
30 Jun 2116500
31 Mar 2117500
31 Dec 2017500
30 Sep 2017600
30 Jun 2018710
31 Mar 2018710
31 Dec 1918700
30 Sep 1918800
30 Jun 1919800
31 Mar 1918900
31 Dec 1817810
30 Sep 1818800
30 Jun 1816710
31 Mar 1817410
31 Dec 1717310
30 Sep 1719610
30 Jun 1719510
31 Mar 1718710
31 Dec 1618810
30 Sep 1616710
30 Jun 1617710
31 Mar 1616610
31 Dec 1516710
30 Sep 1515310
30 Jun 1515310
31 Mar 1514410
31 Dec 1414410
30 Sep 1414400
30 Jun 1414400
31 Mar 1414400
31 Dec 1314400
30 Sep 1315510
30 Jun 1314310

Quality Earnings: M3V has high quality earnings.

Growing Profit Margin: M3V's current net profit margins (28.4%) are lower than last year (41.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: M3V's earnings have declined by 8% per year over the past 5 years.

Accelerating Growth: M3V's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: M3V had negative earnings growth (-36.8%) over the past year, making it difficult to compare to the Healthcare Services industry average (-36.8%).


Return on Equity

High ROE: M3V's Return on Equity (27.6%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.